In the present study, elevated admission serum IL-12 levels are closely related to the inflammation (CRP and TNF-α), hematoma volume, and prognosis in ICH patients, substantializing serum IL-12 levels is an inflammation and prognostic biomarker for ICH. The gene discussed is CRP; the disease is hematoma.